Small interfering RNA targeting of S phase kinase-interacting protein 2 inhibits cell proliferation of pterygium fibroblasts

Molecular Vision

Volumn 17, Issue , 2011, Pages 247-256

  Su, Ying ^a   Wang, Feng ^a   Qi, Hu ^a   Zhao, Shi Guang ^a   Li, Xue ^a   Cui, Hao ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; S PHASE KINASE ASSOCIATED PROTEIN 2; SMALL INTERFERING RNA;

ADULT; AGED; ARTICLE; CELL COUNT; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FIBROBLAST; GENE SILENCING; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; PTERYGIUM; UPREGULATION;

ADULT; AGED; ANIMALS; BROMODEOXYURIDINE; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FEMALE; FIBROBLASTS; HUMANS; MALE; MIDDLE AGED; PTERYGIUM; RABBITS; RNA, SMALL INTERFERING; S-PHASE KINASE-ASSOCIATED PROTEINS; TETRAZOLIUM SALTS; THIAZOLES;

EID: 79551694830     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Hirst LW. The treatment of pterygium. Surv Ophthalmol 2003; 48:145-180. [PMID: 12686302]
2. Ang LPK, Tan DTH, Cajucom-Uy H, Beuerman RW. Autologous cultivated conjunctival transplantation for pterygium surgery. Am J Ophthalmol 2005; 139:611-619. [PMID: 15808155]
3. Tosi G-M, Massaro-Giordano M, Caporossi A, Toti P. Amniotic membrane transplantation in ocular surface disorders. J Cell Physiol 2005; 202:849-851. [PMID:15481064]
4. Coroneo MT, DiGirolamo N, Wakefield D. The pathogenesis of pterygia. Curr Opin Ophthalmol 1999; 10:282-288. [PMID: 10621537]
5. Threlfall TJ, English DR. Sun exposure and pterygium of the eye: a dose-response curve. Am J Ophthalmol 1999; 128:280-287. [PMID: 10511020]
6. Dushku N, John MK, Schultz GS, Reid TW. Pterygia pathogenesis. Arch Ophthalmol 2001; 119:695-706. [PMID: 11346397]
7. Clear AS, Chirambo MC, Hutt MSR. Solar keratosis, pterygium and squamous cell carcinoma of the conjunctiva in Malawi. Br J Ophthalmol 1979; 63:102-109. [PMID: 427069]
8. Tan DT, Liu YP, Sun L. Flow cytometry measurements of DNA content in primary and recurrent pterygia. Invest Ophthalmol Vis Sci 2000; 41:1684-1686. [PMID: 10845586]
9. Chan CM, Liu YP, Tan DT. Ocular surface changes in pterygium. Cornea 2002; 21:38-42. [PMID: 11805505]
10. Chen J-K, Tsai RJF, Lin S-S. Fibroblasts isolated from human pterygia exhibit transformed cell characteristics. In Vitro Cell Dev Biol 1994; 30A:243-248.
11. Ganoth D, Bornstein G, Ko TK, Larsen B, Tyers M, Pagano M, Hershko A. The cell cycle regulatory protein Ckst is required for SCF (Skp2) mediated ubiquitinylation of P27. Nat Cell Biol 2001; 3:321-324. [PMID: 11231585]
12. Akimoto M, Miyahara T, Arai J, Akimoto A, Hamada H, Yoshida Y, Yoshimura N. A new delivery system for 5-fluorouracil using prodrug and converting enzyme. Br J Ophthalmol 2002; 86:581-586. [PMID: 11973258]
13. Johnson KTM, Rodicker F, Heise K, Heinz C, Steuhl KP, Pützer BM, Hudde TAdenoviral p53 gene transfer inhibits human Tenon's capsule fibroblast proliferation.Br J Ophthalmol 2005 89 508-512 [PubMed: 15774934]
14. Carrano AC, Eytan E, Hershko A, Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1999; 1:193-199. [PMID: 10559916]
15. Sutterluty H, Chatelain E, Marti A, Wirbelauer C, Senften M, Müller U, Krek W. p45SKP2 promotes p27 degradation and induces S phase in quiescent cells. Nat Cell Biol 1999; 1:207-214. [PMID: 10559918]
16. Wang F, Qi L, Su Y, Yan QH, Teng Y. S phase kinaseinteracting protein 2 (Skip2) targeting Small interfering RNA inhibits cell proliferation of tenon's capsule fibroblast by increasing p27 protein level. Invest Ophthalmol Vis Sci 2010; 51:1475-1482. [PMID: 19875654]
17. Tseng SH, Chen YT, Cheng HC, Huang FC, Lee SC, Chen FK. Impression cytology study of conjunctival epithelial phenotypes on the healing ocular surface after pterygium excision. Cornea 2001; 20:244-250. [PMID: 11322410]
18. Wang IJ, Lai WT, Liou SW, Chiu CZ, Hu FR, Kao WW, Hung PT. Impression cytology of pterygium. J Ocul Pharmacol Ther 2000; 16:519-528. [PMID: 11132899]
19. Chui J, Di Girolamo N, Coroneo MT. Wakefield. The role of substance P in the pathogenesis of pterygia. Invest Ophthalmol Vis Sci 2007; 48:4482-4489. [PMID: 17898269]
20. Peiretti E, Dessi S, Mulas C, Abete C, Norfo C, Putzolu M, Fossarello M. Modulation of cholesterol homeostasis by antiproliferative drugs in human pterygium fibroblasts. Invest Ophthalmol Vis Sci 2007; 48:3450-3458. [PMID: 17652712]
21. Nolan TM, Di Girolamo N, Coroneo MT, Wakefield D. Proliferative effects of heparin-binding epidermal growth factor-like growth factor on pterygium epithelial cells and fibroblasts. Invest Ophthalmol Vis Sci 2004; 45:110-113. [PMID: 14691161]
22. Solomon A, Grueterich M, Li DQ, Meller D, Lee SB, Tseng SC. Overexpression of insulin-like growth factor-binding protein-2 in pterygium body fibroblasts. Invest Ophthalmol Vis Sci 2003; 44:573-580. [PMID: 12556385]
23. Di Girolamo N, McCluskey PJ, Lloyd A, Coroneo MT, Wakefield D. Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells. Invest Ophthalmol Vis Sci 2000; 41:671-679. [PMID: 10711680]
24. Di Girolamo N, Coroneo MT, Wakefield D. Active matrilysin (MMP-7) in human pterygia: potential role in angiogenesis. Invest Ophthalmol Vis Sci 2001; 42:1963-1968. [PMID: 11481258]
25. Di Girolamo N, Wakefield D, Coroneo MT. Differential expression of matrix metalloproteinases and their tissue inhibitors at the advancing pterygium head. Invest Ophthalmol Vis Sci 2000; 41:4142-4149. [PMID: 11095607]
26. Kria L, Ohira A, Amemiya T. Growth factors in cultured pterygium fibroblasts: immunohistochemical and ELISA analysis. Graefes Arch Clin Exp Ophthalmol 1998; 236:702-708. [PMID: 9782432]
27. Nelsen CJ, Hansen LK, Rickheim DG, Chen C, Stanley MW, Krek W, Albrecht JH. Induction of hepatocyte proliferation and liver hyperplasia by the targeted expression of cyclin E and skp2. Oncogene 2001; 20:1825-1831. [PMID: 11313930]
28. Nakayama K, Nagahama H, Minamishima Y, Matsumoto M, Nakamichi I, Kitagawa K, Shirane M, Tsunematsu R, Tsukiyama T, Ishida N, Kitagawa M, Nakayama K, Hatakeyama S. Targeted disruption of Skp2 results in accumulation of cyclinE and p27, polyploidy and centrosome over duplication. EMBO J 2000; 19:2069-2081. [PMID: 10790373]
29. Wei W, Ayad NG, Wan Y, Zhang GJ, Kirschner MW, Kaelin WG. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature 2004; 428:194-198. [PMID: 15014503]
30. Ezoe S, Matsumura I, Nakata S, Gale K, Ishihara K, Minegishi N, Machii T, Kitamura T, Yamamoto M, Enver T, Kanakura Y. GATA2 estrogen receptor chimer are gulates cytokine dependent growth of hematopoietic cells through accumulation of p21 (WAF1) and p27 (Kip1) proteins. Blood 2002; 100:3512-3520. [PMID: 12393444]
31. Fero ML, Randel E, Gurley KE, Roberts JM, Kemp CJ. The murine gene P27kip1 is haplo insufficient for tumour suppression. Nature 1998; 396:177-180. [PMID: 9823898]
32. Kudo Y, Takata T, Ogawa I, Kaneda T, Sato S, Takekoshi T, Zhao M, Miyauchi M, Nikai H. p27 accumulation by inhibition of proteasome function induces apoptosis in oral squamous cell carcinoma cells. Clin Cancer Res 2000; 6:916-923. [PMID: 10741716]
33. Yoshida K, Nakayama K, Nagahama H, Harada T, Harada C, Imaki J, Matsuda A, Yamamoto K, Ito M, Ohno S, Nakayama K. Involvement of p27(KIP1) degradation by Skp2 in the regulation of proliferation in response to wounding of corneal epithelium. Invest Ophthalmol Vis Sci 2002; 43:364-370. [PMID: 11818378]
34. Buron N, Guery L, Creuzot-Garcher C, Lafontaine PO, Bron A, Rio MC, Solary E. Trefoil Factor TFF1-Induced Protection of Conjunctival Cells from Apoptosis at Premitochondrial and Postmitochondrial Levels. Invest Ophthalmol Vis Sci 2008; 49:3790-3798. [PMID: 18515572]
35. Pardo JM, Fontanilla MR, Ospina LF, Espinosa L. Determining the pharmacological activity of physalis peruviana fruit juice on rabbit eyes and fibroblast primary cultures. Invest Ophthalmol Vis Sci 2008; 49:3074-3079. [PMID: 18579763]